Cyclobenzaprine Hydrochloride
Product Images NDC 16590-544

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 16590-544). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Cyclobenzaprine 5mg Label 544)

Label Image (Cyclobenzaprine 5mg Label 544)
CYCLOBENZAPRINE HYDROCHLORIDE 5 mg tablets, 60 count bottle label distributed by STAT RX USA LLC. The label indicates the product is generic for Flexeril and manufactured by Watson Pharma, Inc., Corona, CA. Includes dosage of 5 mg per tablet, NDC 16590-544-60, lot and sample information, and a warning about alcohol causing drowsiness.*
FDA Label Image

Structure Image (Cyclobenzaprine Structure)

Structure Image (Cyclobenzaprine Structure)
Chemical structure diagram of Cyclobenzaprine Hydrochloride showing the molecular arrangement with a tricyclic ring system and side chains including a hydrochloride group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.